Rosette-Forming Glioneuronal Tumor in Opticochiasmatic Region—Novel Entity in New Location

• Published in: World neurosurgery Vol. 125; pp. 253 - 256
• Main Authors: Sekar, Arunkumar, Rudrappa, Satish, Gopal, Swaroop, Ghosal, Nandita, Rai, Abhishek
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.05.2019
• Subjects: Diagnosis; Management; Opticochiasmatic region; Rosette-forming glioneuronal tumor; Rosette-forming glioneuronal tumor; NF-1; Diagnosis; Management; Opticochiasmatic region; RGNT
• ISSN: 1878-8750; 1878-8769
• DOI: 10.1016/j.wneu.2019.02.003

Rosette-forming glioneuronal tumour [RGNT] is a relatively rare entity first identified as a separate entity in 2002. We are reporting the second case of RGNT in the opticochiasmatic region. We report a case report and literature review of RGNT with syndromic association. Although initial reports were predominantly in the fourth ventricle, many recent reports have identified the possibility of its occurrence outside fourth ventricle in pineal gland, spinal cord, septum pellucidum, lateral ventricle, and suprasellar region. To date, only 1 case of RGNT involving the opticochiasmatic region has been reported in a patient with neurofibromatosis type 1. Genetic analysis of this rare tumor identified 3 hotspots involving somatic mutations of FGFR-1 and PIK3CA and a germline mutation involving PTPN11, which can be targets for therapeutic intervention in cases where complete resection is not possible. To the best of our knowledge, we report the first case of RGNT involving the opticochiasmatic region without any syndromic association. Other cases of RGNT with syndromic associations provide us with insight into possible therapeutic interventions.